Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_assertion type Assertion NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_head.
- NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_assertion description "[These results suggest that FGF21 could be a novel and attractive drug candidate for the treatment of cardiovascular disease, obesity and type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_provenance.
- NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_assertion evidence source_evidence_literature NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_provenance.
- NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_assertion SIO_000772 19337957 NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_provenance.
- NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_assertion wasDerivedFrom befree-20140225 NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_provenance.
- NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_assertion wasGeneratedBy ECO_0000203 NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_provenance.